APIXABAN AND SODIUM THIOSULFATE IN CALCIPHYLAXIS: UNEXPECTED SUCCESSFUL COMBINATION THERAPY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/7d54cf9fafed177abfb98bf45f6e9eea.pdf
APIXABAN AND SODIUM THIOSULFATE IN CALCIPHYLAXIS: UNEXPECTED SUCCESSFUL COMBINATION THERAPY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Mouna
Jerbi
Mouna Jerbi mouna.jerbi@fmt.utm.tn Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department Tunis Tunisia *
Ibtissem Ben Nacef ibtissem.bennacef@fmt.utm.tn Charles Nicolle Hospital Endocrinology Department Tunis Tunisia -
Asma Bettaieb asma.bettaieb@fmt.utm.tn Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department tunis Tunisia -
Raja Aoudia rajoi2000@yahoo.fr Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department tunis Tunisia -
Mariem Khadhar Meriam.khadhar@fmt.utm.tn Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department tunis Tunisia -
Sarra Hadded sarra.hadded@fmt.utm.tn Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department tunis Tunisia -
Rym Goucha rim.goucha@fmt.utm.tn Mongi Slim Hospital, Renal Pathology Research Laboratory, LR00SP01, Faculty of Medicine, University of Tunis El Manar Nephrology Department tunis Tunisia -
Hayet Kaaroud hayet.kaaroud@fmt.utm.tn Charles Nicolle Hospital Renal Pathology Research Laboratory, LR00SP01 tunis Tunisia -
-
-
-
-
-
-
-